Showing results (61-70 of 179) with videos related to
Sort By:
Pageof 18
Frontiers in Oncology|October 5, 2020
Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 InhibitorsJinxin Che, Ruiwei Feng, Jian Gao, et al.ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of 1,5-Dihydro-4H-imidazol-4-one Derivatives as Potent, Selective Antagonists of CXC Chemokine Receptor 2Jinxin Che, Zhilong Wang, Zheyuan Shen, et al.Translational Cancer Research|February 4, 2022
Bruton's tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distributionHaifeng Yu, Haiying Kong, Cong Li, et al.European Journal of Medicinal Chemistry|October 20, 2022
Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancersMengxin Luo, Yongjin Xu, Haifeng Chen, et al.Bioorganic Chemistry|May 15, 2022
Design, synthesis and biological evaluation of new dihydropyridine derivatives as PD-L1 degraders for enhancing antitumor immunityChenghao Pan, Mengxin Luo, Yang Lu, et al.Bioorganic & Medicinal Chemistry|August 23, 2011
Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitorsChunqi Hu, Xin Li, Weisi Wang, et al.European Journal of Medicinal Chemistry|April 19, 2026
Programmed cell death in acute kidney injury: From molecular mechanisms to targeted therapiesBingyang Xu, Yuanyuan Zheng, Yao Hu, et al.Journal of Multidisciplinary Healthcare|December 11, 2025
From Mind to Liver: Exploring the Causal Relationship Between Anxiety Disorders and Non-Alcoholic Fatty Liver Disease Through Mendelian Randomization and UK Biobank ValidationHui Song, Xiaowu Dong, Qinghui Niu, et al.Bioorganic & Medicinal Chemistry|November 12, 2010
Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agentsJing Chen, Tao Liu, Rui Wu, et al.European Journal of Medicinal Chemistry|June 18, 2025
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitorsHaibin Yuan, Yue Gao, Peipei Wang, et al.Pageof 18